| William Cole Andrew, DO | |
|
14 Richland Medical Park Dr Ste 320, Columbia, SC 29203 | |
| (803) 434-8721 | |
| Not Available |
| Full Name | William Cole Andrew |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 9 Years |
| Location | 14 Richland Medical Park Dr Ste 320, Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003295171 | NPI | - | NPPES |
| 376300 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 37630 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Baptist | Columbia, SC | Hospital |
| Prisma Health Richland Hospital | Columbia, SC | Hospital |
| Prisma Health Baptist Parkridge | Columbia, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health Medical Group-midlands | 5991099707 | 865 |
News Archive
A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all [multi-drug resistant] patients who need it," WHO Director-General Margaret Chan said, Times LIVE reports.
A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis.
Natasha Leporé, PhD, a principal investigator in the Department of Radiology and Imaging at Children's Hospital Los Angeles, has been awarded $1.7 million from the National Institute of Biomedical Imaging and Bioengineering of the NIH to study the impact of prematurity on brain development.
CEL-SCI Corporation announced today that it has expanded the licensing agreement with Teva Pharmaceutical Industries Ltd. for its cancer drug Multikine.
› Verified 1 days ago
| Entity Name | Prisma Health Medical Group-midlands |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275988321 PECOS PAC ID: 5991099707 Enrollment ID: O20160802001226 |
News Archive
A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all [multi-drug resistant] patients who need it," WHO Director-General Margaret Chan said, Times LIVE reports.
A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis.
Natasha Leporé, PhD, a principal investigator in the Department of Radiology and Imaging at Children's Hospital Los Angeles, has been awarded $1.7 million from the National Institute of Biomedical Imaging and Bioengineering of the NIH to study the impact of prematurity on brain development.
CEL-SCI Corporation announced today that it has expanded the licensing agreement with Teva Pharmaceutical Industries Ltd. for its cancer drug Multikine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Cole Andrew, DO Po Box 743904, Atlanta, GA 30374-3904 Ph: (803) 296-7320 | William Cole Andrew, DO 14 Richland Medical Park Dr Ste 320, Columbia, SC 29203 Ph: (803) 434-8721 |
News Archive
A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all [multi-drug resistant] patients who need it," WHO Director-General Margaret Chan said, Times LIVE reports.
A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis.
Natasha Leporé, PhD, a principal investigator in the Department of Radiology and Imaging at Children's Hospital Los Angeles, has been awarded $1.7 million from the National Institute of Biomedical Imaging and Bioengineering of the NIH to study the impact of prematurity on brain development.
CEL-SCI Corporation announced today that it has expanded the licensing agreement with Teva Pharmaceutical Industries Ltd. for its cancer drug Multikine.
› Verified 1 days ago
Seetharamprasad Madala, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Sunset Dr, Columbia, SC 29203 Phone: 803-434-4153 Fax: 803-434-4160 | |
Michael Martin, Internal Medicine Medicare: Medicare Enrolled Practice Location: 2 Medical Park Rd, Columbia, SC 29203 Phone: 803-434-6956 | |
Dr. Terry A Grainger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Richland Medical Park Dr Ste 100, Columbia, SC 29203 Phone: 803-434-3800 Fax: 803-744-2759 | |
Dr. Adelero Olayinka Adebajo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1520 Laurel St, Columbia, SC 29201 Phone: 803-799-8407 Fax: 803-252-9070 | |
Jeff Z Brooker Jr., MD, RETIRED Internal Medicine Medicare: Medicare Enrolled Practice Location: 1625 Bernardin Ave, Columbia, SC 29204 Phone: 803-251-8985 | |
Dr. Ronald L Collins, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1711 Saint Julian Pl, Columbia, SC 29204 Phone: 803-779-0911 Fax: 803-256-2480 |